Adverse drug reaction to tremelimumab and durvalumab in hepatocellular carcinoma patients: an analysis of the food and drug administration adverse event reporting system database by Wei Fan Sui, Yu Xin Duan, Ze Feng Cai, Yi Mao Xia, Jian Yun Li, Jian Hua Fu

Get full text